Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer

Emerging evidence suggests that metformin, a widely used anti-diabetic drug, may be useful in the prevention and treatment of different cancers. In the present study, we demonstrate that metformin directly inhibits the enzymatic function of hexokinase (HK) I and II in a cell line of triple-negative...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Marini, Cecilia, Salani, Barbara, Massollo, Michela, Amaro, Adriana, Esposito, Alessia Isabella, Orengo, Anna Maria, Capitanio, Selene, Emionite, Laura, Riondato, Mattia, Bottoni, Gianluca, Massara, Cinzia, Boccardo, Simona, Fabbi, Marina, Campi, Cristina, Ravera, Silvia, Angelini, Giovanna, Morbelli, Silvia, Cilli, Michele, Cordera, Renzo, Truini, Mauro, Maggi, Davide, Pfeffer, Ulrich, Sambuceti, Gianmario
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2013
Matèries:
Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3906335/
https://ncbi.nlm.nih.gov/pubmed/24240433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cc.26461
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars